Menu
Biosimilars provide a unique opportunity to help manage the growing costs of biological medicines on the PBS. They offer therapeutically equivalent and cost-effective alternatives to existing, high-cost biological medicines. This means that savings can be made, or more patients can be treated within the same budget.
The information a reader is about to be referred to may not comply with the Australian regulatory requirements.
Further information relevant to the Australian environment is available from the Australian Government, Department of Health.
Please click “Continue” to leave this website and proceed to the selected site.